Author:
Kim Tae-Heon,Jeong Jong-Woo,Song Ji-Hye,Lee Kyeong-Ryoon,Ahn Sunjoo,Ahn Sung-Hoon,Kim Sungsub,Koo Tae-Sung
Publisher
Springer Science and Business Media LLC
Subject
Organic Chemistry,Drug Discovery,Molecular Medicine
Reference22 articles.
1. Astellas. 2012. Full prescribing information. http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203415lbl.pdf .
2. Astellas. 2014. Product monograph. http://www.cmsastellas.ca/uploads/pdf/Xtandi_PM_EN-Approved.pdf .
3. Crawford, E.D., M.A. Eisenberger, D.G. McLeod, J.T. Spaulding, R. Benson, F.A. Dorr, B.A. Blumenstein, M.A. Davis, and P.J. Goodman. 1989. A controlled trial of leuprolide with and without flutamide in prostatic carcinoma. The New England Journal of Medicine 321: 419–424.
4. Davies, B., and T. Morris. 1993. Physiological parameters in laboratory animals and humans. Pharmaceutical Research 10: 1093–1095.
5. El-Amm, J., N. Patel, A. Freeman, and J.B. Aragon-Ching. 2013. Metastatic castration-resistant prostate cancer: critical review of enzalutamide. Clinical Medicine Insights: Oncology 7: 235–245.
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献